"Disorders of GABA metabolism: SSADH and GABA-transaminase deficiencies"
174176 A notably comparable study is the population-based cohort analysis by Gamble et al, 174 which utilized UK databases to assess the incidence of new-onset depression or self-harm among new users of GLP-1RAs and dipeptidyl peptidase-4 inhibitors relative to sulfonylureas
Recalls & Warnings October 22, 2019 Company Marketing CBD for Use in Infants and Children Gets Strong Warning On October 10, 2019, the FDA and FTC issued a joint warning letter to Rooted Apothecary LLC for "illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims" including that the products could treat teething pain and ear aches in infants, autism,
The analysis showed significantly greater WL in the GLP-1RAs group compared to placebo (SMD = 0.82, 95% CI 0.23 to 1.42)
The other switched to placebo, effectively stopping the medication